Description
The preparation causes specific lysis of bacteria Klebsiella pneumoniae, Klebsiella ozaenae, Klebsiella rhinoscleromatis.
Presentation
Solution for oral, topical and external use in 20 ml vials. 4 bottles with instructions for use in a carton pack. 4 vials in a contoured cell package made of polyvinylchloride film. 1 contoured cell package with instructions for use in a carton pack.
Ingredients
1 ml of the drug contains:
Active ingredient:
Sterile purified filtrate of phagolysates of Klebsiella pneumoniae bacteria (with an Appelman activity of at least 10-4 ) - up to 1 ml.
Excipients:
8-hydroxyquinoline sulfate monohydrate (preservative) in terms of 8-hydroxyquinoline sulfate - 0.0001 g/mL (content calculated).
Indications
Treatment and prevention of diseases caused by Klebsiella pneumoniae bacteria as part of complex therapy:
-
diseases of the gastrointestinal tract (gastroenterocolitis, cholecystitis, pancreatitis, intestinal dysbacteriosis);
-
inflammatory diseases of newborns and infants (gastroenterocolitis, intestinal dysbacteriosis, omphalitis, pemphigus, pyoderma, septicemia and septicopiemia of various localizations);
-
surgical infections (wound suppuration, purulent skin lesions, burns, peritonitis, pleurisy, mastitis, osteomyelitis, abscess);
-
urogenital infections (cystitis, pyelonephritis, urethritis, endometritis, vulvitis, bartolinitis, colpitis, salpingo-ophoritis);
-
purulent-inflammatory diseases of the ear, throat, nose, sinuses, oral cavity, pharynx, larynx, bronchi, lungs and pleura (otitis, sore throat, pharyngitis, laryngitis, stomatitis, periodontitis, maxillary sinusitis, frontitis, bronchitis, pneumonia, pleurisy);
-
post-traumatic conjunctivitis, keratoconjunctivitis, purulent corneal ulcer and iridocyclitis;
-
prevention of nosocomial infections caused by Klebsiellae.
